Conversely, defective donor CD8 CTL formation in D2→F1 can be corrected by administration of rIL-12 if given in the first 5 days after transfer, which converts the 2-week disease phenotype from chronic to acute GVHD [54]. The gene discussed is CD8A; the disease is acute graft versus host disease.